Recent medical studies and experiments have revealed the development of an injectable foam material that may bring about a qualitative shift in the treatment of acute internal bleeding, which is one of the most prominent causes of death in cases of accidents and serious injuries.
RevMedx, an American company specialized in developing bleeding control technologies, announced that it has developed a new foam material, ResQFoam™, designed to treat acute internal bleeding in the abdomen, and reported its successful use in a clinical study.
The new technology relies on injecting medical foam into the abdominal cavity, where it expands quickly to fill the void and put pressure on the bleeding tissue, which helps slow or stop the bleeding temporarily until surgical intervention is performed.
Internal bleeding, especially in the abdominal area, is one of the most dangerous medical conditions, as medical data indicate that a large percentage of those infected may lose their lives even after arriving at the hospital due to rapid blood loss.
These foam materials work through multiple mechanisms, including creating internal pressure on the source of bleeding, stimulating blood vessel constriction and accelerating blood clotting, which contributes to significantly reducing blood loss.
According to a report published by Business Wire, this substance is injected into the abdominal cavity, where it expands quickly to generate internal pressure that contributes to reducing bleeding, which gives doctors additional time to transport the injured person and perform the necessary surgical intervention to treat the main cause.
Recent experiments have also shown that some of these foams are able to self-expand and adapt to the shape of the affected tissue, and even adhere to it, which makes them effective even in complex cases in which it is difficult to accurately determine the source of bleeding.
In preliminary clinical trials, this technology helped stabilize the condition of patients who arrived in critical condition after serious accidents, by buying valuable time before they were admitted to the operating room, which may significantly increase the chances of survival.
Despite the promising results, this technology is still in the clinical trial stages, and has not yet received widespread adoption, as doctors warn of potential risks such as infections or side effects, stressing the need for more studies before its general use.
Specialists believe that this innovation may represent a “medical achievement” in the field of emergency medicine, especially in war zones and major accidents, where time is a decisive factor between life and death.
Dr. Preston Huguley, the lead researcher, explained that the use of foam contributed to stabilizing the condition of a patient who arrived at the hospital in critical condition following a traffic accident, as blood pressure and heart rate indicators improved, before he later left the hospital after recovering.
Intra-abdominal bleeding is one of the most dangerous types of bleeding, as blood loss occurs internally as a result of injury or illness, which makes rapid intervention crucial to saving a life.